|
1
|
Makker V, MacKay H, Ray-Coquard I, Levine
DA, Westin SN, Aoki D and Oaknin A: Endometrial cancer. Nat Rev Dis
Primers. 7:882021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vizza E, Bruno V, Cutillo G, Mancini E,
Sperduti I, Patrizi L, Certelli C, Zampa A, Giannini A and Corrado
G: Prognostic role of the removed vaginal cuff and its correlation
with L1CAM in low-risk endometrial adenocarcinoma. Cancers (Basel).
14:342021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crosbie EJ, Kitson SJ, McAlpine JN,
Mukhopadhyay A, Powell ME and Singh N: Endometrial cancer. Lancet.
399:1412–1428. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Henley SJ, Ward EM, Scott S, Ma J,
Anderson RN, Firth AU, Thomas CC, Islami F, Weir HK, Lewis DR, et
al: Annual report to the nation on the status of cancer, part I:
National cancer statistics. Cancer. 126:2225–2249. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arend RC, Jones BA, Martinez A and
Goodfellow P: Endometrial cancer: Molecular markers and management
of advanced stage disease. Gynecol Oncol. 150:569–580. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Doll KM, Tseng J, Denslow SA, Fader AN and
Gehrig PA: High-grade endometrial cancer: Revisiting the impact of
tumor size and location on outcomes. Gynecol Oncol. 132:44–49.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cancer Genome Atlas Research Network, .
Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H,
Robertson AG, Pashtan I, Shen R, et al: Integrated genomic
characterization of endometrial carcinoma. Nature. 497:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
DeBerardinis RJ and Chandel NS: We need to
talk about the Warburg effect. Nat Metab. 2:127–129. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Warburg O: The metabolism of carcinoma
cells. J Cancer Res. 9:148–163. 1925. View Article : Google Scholar
|
|
13
|
Warburg OH: Ueber den stoffwechsel der
tumoren. Springer; Berlin: 1926
|
|
14
|
Pilkis SJ, Claus TH, Kurland IJ and Lange
AJ: 6-Phosphofructo-2-kinase/fructose-2, 6-bisphosphatase: A
metabolic signaling enzyme. Annu Rev Biochem. 64:799–835. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dasgupta S, Rajapakshe K, Zhu B, Nikolai
BC, Yi P, Putluri N, Choi JM, Jung SY, Coarfa C, Westbrook TF, et
al: Metabolic enzyme PFKFB4 activates transcriptional coactivator
SRC-3 to drive breast cancer. Nature. 556:249–254. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Q, Zeng F, Sun Y, Qiu Q, Zhang J,
Huang W, Huang J, Huang X and Guo L: Etk interaction with PFKFB4
modulates chemoresistance of small-cell lung cancer by regulating
AutophagyEtk controls PFKFB4 in promoting chemoresistance of SCLC.
Clin Cancer Res. 4:950–962. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang F, Wu X, Li Y, Cao X, Zhang C and Gao
Y: PFKFB4 as a promising biomarker to predict a poor prognosis in
patients with gastric cancer. Oncol Lett. 21:2962021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yun SJ, Jo SW, Ha YS, Lee OJ, Kim WT, Kim
YJ, Lee SC and Kim WJ: PFKFB4 as a prognostic marker in
non-muscle-invasive bladder cancer. Urol Oncol. 30:893–899. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yi M, Ban Y, Tan Y, Xiong W, Li G and
Xiang B: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and
4: A pair of valves for fine-tuning of glucose metabolism in human
cancer. Mol Metab. 20:1–13. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kotowski K, Rosik J, Machaj F, Supplitt S,
Wiczew D, Jabłońska K, Wiechec E, Ghavami S and Dzięgiel P: Role of
PFKFB3 and PFKFB4 in cancer: Genetic basis, impact on disease
development/progression, and potential as therapeutic targets.
Cancers (Basel). 13:9092021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li W, Qian L, Lin J, Huang G, Hao N, Wei
X, Wang W and Liang J: CD44 regulates prostate cancer
proliferation, invasion and migration via PDK1 and PFKFB4.
Oncotarget. 8:65143–65151. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu C, Qiao P, Fu R, Wang Y, Lu J, Ling X,
Liu L, Sun Y, Ren C and Yu Z: Phosphorylation of PFKFB4 by PIM2
promotes anaerobic glycolysis and cell proliferation in
endometriosis. Cell Death Dis. 13:7902022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, Deng CX and Chen Q: SRC-3, a steroid
receptor coactivator: Implication in cancer. Int J Mol Sci.
22:47602021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han SJ, Jain P, Gilad Y, Xia Y, Sung N,
Park MJ, Dean AM, Lanz RB, Xu J, Dacso CC, et al: Steroid receptor
coactivator 3 is a key modulator of regulatory T cell-mediated
tumor evasion. Proc Natl Acad Sci USA. 120:e22217071202023.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bijou I, Liu Y, Lu D, Chen J, Sloan S,
Alinari L, Lonard DM, O'Malley BW, Wang M and Wang J: Inhibition of
SRC-3 as a potential therapeutic strategy for aggressive mantle
cell lymphoma. PLoS One. 19:e02899022024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Varisli L, Dancik GM, Tolan V and
Vlahopoulos S: Critical roles of SRC-3 in the development and
progression of breast cancer, rendering it a prospective clinical
target. Cancers (Basel). 15:52422023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Percie du Sert N, Hurst V, Ahluwalia A,
Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl
U, et al: The ARRIVE guidelines 2.0: Updated guidelines for
reporting animal research. PLoS Biol. 18:e30004102020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jia Y, Liu J, Shi J, Zhang C, Wang X, Zhao
L, Lou Y, Guan X and Huangfu H: Epigenetic silencing of JAM3
promotes laryngeal squamous cell carcinoma development by
inhibiting the Hippo pathway. Oncol Rep. 53:282025. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Riener MO, Fritzsche FR, Clavien PA,
Pestalozzi BC, Probst-Hensch N, Jochum W and Kristiansen G: IMP3
expression in lesions of the biliary tract: A marker for high-grade
dysplasia and an independent prognostic factor in bile duct
carcinomas. Hum Pathol. 40:1377–1383. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim J and DeBerardinis RJ: Mechanisms and
implications of metabolic heterogeneity in cancer. Cell Metab.
30:434–446. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wiel C, Le Gal K, Ibrahim MX, Jahangir CA,
Kashif M, Yao H, Ziegler DV, Xu X, Ghosh T, Mondal T, et al: BACH1
stabilization by antioxidants stimulates lung cancer metastasis.
Cell. 178:330–345. e222019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bartrons R and Caro J: Hypoxia, glucose
metabolism and the Warburg's effect. J Bioenerg Biomembr.
39:223–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang JB, Erickson JW, Fuji R, Ramachandran
S, Gao P, Dinavahi R, Wilson KF, Ambrosio AL, Dias SM, Dang CV and
Cerione RA: Targeting mitochondrial glutaminase activity inhibits
oncogenic transformation. Cancer Cell. 18:207–219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Goidts V, Bageritz J, Puccio L, Nakata S,
Zapatka M, Barbus S, Toedt G, Campos B, Korshunov A, Momma S, et
al: RNAi screening in glioma stem-like cells identifies PFKFB4 as a
key molecule important for cancer cell survival. Oncogene.
31:3235–3243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao R, Liu Y, Li D, Xun J, Zhou W, Wang P,
Liu C, Li X, Shen W, Su W, et al: PFKFB4 promotes breast cancer
metastasis via induction of hyaluronan production in a
p38-dependent manner. Cell Physiol Biochem. 50:2108–2123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ros S, Flöter J, Kaymak I, Da Costa C,
Houddane A, Dubuis S, Griffiths B, Mitter R, Walz S, Blake S, et
al: 6-Phosphofructo-2-kinase/fructose-2, 6-biphosphatase 4 is
essential for p53-null cancer cells. Oncogene. 36:3287–3299. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chesney J, Clark J, Lanceta L, Trent JO
and Telang S: Targeting the sugar metabolism of tumors with a
first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor.
Oncotarget. 6:18001–18011. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chesney J, Clark J, Klarer AC,
Imbert-Fernandez Y, Lane AN and Telang S: Fructose-2,
6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,
6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response
to hypoxia and tumor growth. Oncotarget. 5:6670–6686. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sun CM, Xiong DB, Yan Y, Geng J, Liu M and
Yao XD: Genetic alteration in phosphofructokinase family promotes
growth of muscle-invasive bladder cancer. Int J Biol Markers.
31:e286–e293. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang H, Lu C, Fang M, Yan W, Chen M, Ji
Y, He S, Liu T, Chen T and Xiao J: HIF-1α activates hypoxia-induced
PFKFB4 expression in human bladder cancer cells. Biochem Biophys
Res Commun. 476:146–152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang P, Tao W, Lu C, Fan L, Jiang Q, Yang
C, Shang E, Cheng H, Che C, Duan J and Zhao M: Bruceine A induces
cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling
in pancreatic cancer. Pharmacol Res. 169:1056582021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang G, Li S, Xue K and Dong S: PFKFB4 is
critical for the survival of acute monocytic leukemia cells.
Biochem Biophys Res Commun. 526:978–985. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dang CV: Cancer cell metabolism: There is
no ROS for the weary. Cancer Discov. 2:304–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lu Z and Hunter T: Metabolic kinases
moonlighting as protein kinases. Trends Biochem Sci. 43:301–310.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang J, Ren B, Yang G, Wang H, Chen G, You
L, Zhang T and Zhao Y: The enhancement of glycolysis regulates
pancreatic cancer metastasis. Cell Mol Life Sci. 77:305–321. 2020.
View Article : Google Scholar : PubMed/NCBI
|
